NewEdge Advisors, LLC - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 34 filers reported holding AIM IMMUNOTECH INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NewEdge Advisors, LLC ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q2 2024$010.0%0.00%
Q1 2024$010.0%0.00%
Q4 2023$010.0%0.00%
Q3 2023$0
-100.0%
10.0%0.00%
Q2 2023$110.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q2 2023
NameSharesValueWeighting ↓
Anson Funds Management LP 515,124$393,0000.29%
SABBY MANAGEMENT, LLC 185,171$141,0000.08%
Hudson Bay Capital Management LP 394,900$301,0000.01%
UBS Group AG 20$00.00%
Advisor Group, Inc. 6$00.00%
Jacobi Capital Management LLC 8$00.00%
Realta Investment Advisors 85$00.00%
CREDIT AGRICOLE S A 1$00.00%
A.R.T. Advisors, LLC 12,369$9,0000.00%
BlackRock Inc. 10,525$8,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders